ClinVar Miner

Submissions for variant NM_000155.4(GALT):c.617A>G (p.Gln206Arg)

dbSNP: rs1587239309
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Labcorp Genetics (formerly Invitae), Labcorp RCV000805776 SCV000945744 pathogenic Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase 2022-12-23 criteria provided, single submitter clinical testing For these reasons, this variant has been classified as Pathogenic. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt GALT protein function. ClinVar contains an entry for this variant (Variation ID: 650599). This missense change has been observed in individual(s) with galactosemia (PMID: 22743281; Invitae). This variant is not present in population databases (gnomAD no frequency). This sequence change replaces glutamine, which is neutral and polar, with arginine, which is basic and polar, at codon 206 of the GALT protein (p.Gln206Arg).
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories RCV000805776 SCV001157990 likely pathogenic Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase 2018-11-06 criteria provided, single submitter clinical testing The GALT c.617A>G; p.Gln206Arg variant is reported in the literature in the homozygous state in an individual with classic galactosemia (Liu 2012). This variant is absent from general population databases (Exome Variant Server, Genome Aggregation Database), indicating it is not a common polymorphism. The glutamine at codon 206 is moderately conserved, and computational analyses (SIFT, PolyPhen-2) predict that this variant is deleterious. Consistent with these predictions, an in vitro GALT assay suggested the p.Gln206Arg variant exhibits negligible activity compared to wildtype protein (Spencer 2013). Based on available information, this variant is considered to be likely pathogenic. References: Liu Y et al. N- and O-linked glycosylation of total plasma glycoproteins in galactosemia. Mol Genet Metab. 2012 Aug;106(4):442-54. Spencer JB et al. Modifiers of ovarian function in girls and women with classic galactosemia. J Clin Endocrinol Metab. 2013 Jul;98(7):E1257-65.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.